• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND ACCOLADE; IMPLANTABLE PULSE GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND ACCOLADE; IMPLANTABLE PULSE GENERATOR Back to Search Results
Model Number U128
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Death (1802); Electro-Mechanical Dissociation (1826); Unspecified Infection (1930); Sepsis (2067)
Event Date 01/25/2017
Event Type  Death  
Manufacturer Narrative
The local representative was notified on february 13, 2017 by a health care professional (hcp) that this patient had died on (b)(6) 2017.According to the hcp, the patient's latitude monitoring system was reviewed and no issues were identified.A family member mentioned that throughout the night of (b)(6), the patient's blood sugars were checked because of low measurements.Because the patient's blood sugars continued to be low, glucagon was given.Blood sugars were not checked after glucagon was given.The family member contacted the paramedics.The paramedics informed the family member that from the ekg, there was pacing output but the patient had no pulse.The patient's family did not have an autopsy done.The device was received at boston scientific's return product department and is currently undergoing laboratory testing.
 
Event Description
Boston scientific received information from the local representative that this patient had been scheduled for a pocket revision on (b)(6) 2017 due to pocket erosion.The patient was presented to the electrophysiology (ep) laboratory.Due to scar tissue and oozing of the pocket, the procedure required an extended period of time to complete.There were no patient adverse event and the system remained in-service.On (b)(6) 2017, the patient was scheduled for a device and lead extraction due to infection/sepsis and erosion.This surgical procedure was scheduled in the hospital's operating room.The local representative had contacted boston scientific's technical services on the day of system explant to report that the patient was pacemaker dependent and the physician planned to place a permanent pacing lead for bradycardia on the opposite side.Additionally, the physician was planning to use the chronic left ventricular (lv) lead for bradycardia pacing support until the system was extracted and the permanent system placed on the opposite side.Before the procedure, the local representative was informed by the physician that the patient was seen by a hospitalist between the revision and explant procedure.The hospitalist may have disrupted the incision possibly leading to the erosion and infection.The chronic system was explanted and a replacement system was implanted on the patient's opposite side.The physician did have difficulty removing the fineline lead.The lead was destroyed or came apart due to the extraction tool cutting through it.The patient spent a couple of days in the hospital without incident.The patient was discharged from the hospital on (b)(6) 2017.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted no anomalies.Visual and mechanical inspection of the set screws was performed.The set screws were found to move normally and completely in both clockwise and counter clockwise directions.A cut was noted in the left ventricular (lv) seal plug.The other seal plugs were intact and undamaged.Analysis of the device memory noted no irregularities.No battery faults were present and the battery status of the device was good associated with a battery voltage of 3.003 volts.The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCOLADE
Type of Device
IMPLANTABLE PULSE GENERATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key6387304
MDR Text Key69358400
Report Number2124215-2017-03892
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526559402
UDI-Public(01)00802526559402(17)20181027
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/27/2018
Device Model NumberU128
Other Device ID NumberVALITUDE X4
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/23/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 02/08/2017
Initial Date FDA Received03/08/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received03/27/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
4470; 4674; 7742; L131; U128
Patient Outcome(s) Death; Hospitalization; Life Threatening; Required Intervention;
Patient Age71 YR
-
-